BigDeal cover image

The Case for Ozempic, Weed’s Risks, and Big Pharma Conspiracies | Mike Israetel

BigDeal

00:00

Rethinking Corporate Health Responsibilities

This chapter examines the changing perspectives on drug and food companies, particularly after vaccine rollouts and rising obesity rates. It argues for the potential of these corporations to prioritize health and wellness over profit motives, while also addressing consumer responsibility in health decisions. The discussion further critiques the notion of pharmaceutical greed and promotes a collaborative, long-term approach to corporate practices that benefit society.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app